pancreatic%20cancer
PANCREATIC CANCER
Pancreatic cancer is malignancy arising from the pancreas.
It is the 13th most common cancer in the world, 10th most common in the United States, and 4th leading cause of cancer-related deaths in the United Stated and Europe.
Exocrine tumors account for 95% of malignant pancreatic disease.
It is more common in women.
The median age of occurrence is at 71 years old.

Pancreatic%20cancer Management

Follow Up

  • Assess for suspected recurrence
  • Patients with poor prognostic or high-risk features for disseminated disease include patients with:
    • Large primary tumors
    • Large regional lymph nodes
    • Markedly elevated CA 19-9
    • Extreme pain, excessive weight loss or highly symptomatic
    • Borderline resectable tumors
  • Recommended follow-up schedules:
    • 1st 2 years: History and physical examination, CA 19-9 and CT scan every 3-6 months
    • 3rd year and thereafter: History and physical examination, CA 19-9 and CT scan annually
  • For post-op patients:
    • If with elevated serum CA 19-9 levels, serum CA should be measured every 3 months for 2 years and abdominal CT scan performed every 6 months
    • Insulin therapy may be prescribed after total pancreatectomy

Prevention

  • There are no definite measures to prevent PC but there are measures which can lower the risk for pancreatic cancer
Alcohol Consumption
  • Avoid or limit consumption of alcohol
Diet
  • Increase consumption of vegetables and whole grains
  • Decrease consumption of sugar
Exposure to Chemicals
  • Avoid exposure to certain chemicals
Smoking
  • Most established and most avoidable risk factor for PC
  • Patients should be discouraged from smoking, or for smokers, encouraged to quit smoking
Weight Management
  • Maintain normal body weight
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 3 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
4 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.